Immunic, Inc. ( IMUX) - Stock Earnings

IMUX Quarterly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2025Q4 -19.3 million USD — USD
2026Q1 -32.6 million USD — USD
2026Q2 -34.1 million USD — USD
2026Q3 Est.
2026Q4 Est.
2027Q1 Est.

IMUX Yearly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2023 -93.6 million USD — USD
2024 -100.5 million USD — USD
2025 -97.2 million USD — USD
2026 Est.

IMUX

Price: $16.83

52 week price:
5.06
16.83

Earnings Per Share: -3.67 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 562646

Market Capitalization: 217.4 million

Links: